← Back to catalogue
Audit MicroControls Control FD COVID-19 Antigen – Nucleocapsid
FDA UDIIdentity
- Trade Name
- Audit MicroControls Control FD COVID-19 Antigen – Nucleocapsid FDA UDI
- Generic Name
- SARS-CoV-2 antigen IVD, control FDA UDI
- Model / Reference
- K086M-6 FDA UDI
Identifiers
- Primary DI / UDI-DI
- B085K086M60 FDA UDI
- GMDN Term
- SARS-CoV-2 antigen IVD, control FDA UDI
Classification
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
No
FDA UDI
Single Use
No
FDA UDI
Implantable
No
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
No
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
Yes
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
Yes
FDA UDI
Lot / Batch Number
Yes
FDA UDI
Serial Number
No
FDA UDI
Expiration Date
Yes
FDA UDI
Manufacturing Date
No
FDA UDI
Category: SARS-CoV-2 antigen IVD, control
Audit MicroControls Control FD COVID-19 Antigen – Nucleocapsid by Aalto Scientific, Ltd. — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Similar devices
Also classified as SARS-CoV-2 antigen IVD, control.
- SARS-CoV-2 Control Slides — BIO SB, INC. · Class I
- BinaxNOW COVID-19 Ag Positive Control Swab Pack — Alere Scarborough, Inc. · N
- WELLlife™ — WONDFO USA CO., LTD. · N
- Helix Elite™ Molecular Standards: Inactivated Standard — MICROBIOLOGICS, INC. · Class I
- Lumipulse SARS-CoV-2 Ag Controls — FUJIREBIO INC.
- VITROS — Ortho-Clinical Diagnostics · N
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | N/A | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Aalto Scientific, Ltd.
Sources (1)
- FDA UDI 8e32e101-3570-4540-b42d-7b35e84e81a9 32 fields · synced May 31, 2026